353 related articles for article (PubMed ID: 20679404)
41. [Inflammatory bowel disease: IBD].
Endo K; Shiga H; Kinouchi Y; Shimosegawa T
Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
[TBL] [Abstract][Full Text] [Related]
42. Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?!
Pantazi E; Powell N
Front Immunol; 2019; 10():676. PubMed ID: 31024537
[TBL] [Abstract][Full Text] [Related]
43. Development and survival of Th17 cells within the intestines: the influence of microbiome- and diet-derived signals.
Chewning JH; Weaver CT
J Immunol; 2014 Nov; 193(10):4769-77. PubMed ID: 25381358
[TBL] [Abstract][Full Text] [Related]
44. Role of interleukin-22 in inflammatory bowel disease.
Li LJ; Gong C; Zhao MH; Feng BS
World J Gastroenterol; 2014 Dec; 20(48):18177-88. PubMed ID: 25561785
[TBL] [Abstract][Full Text] [Related]
45. Linking immunity, epigenetics, and cancer in inflammatory bowel disease.
Däbritz J; Menheniott TR
Inflamm Bowel Dis; 2014 Sep; 20(9):1638-54. PubMed ID: 24896241
[TBL] [Abstract][Full Text] [Related]
46. Biological pathways involved in the development of inflammatory bowel disease.
Zemljic M; Pejkovic B; Krajnc I; Lipovsek S
Wien Klin Wochenschr; 2014 Oct; 126(19-20):626-33. PubMed ID: 25256178
[TBL] [Abstract][Full Text] [Related]
47. Control of intestinal homeostasis through crosstalk between natural killer T cells and the intestinal microbiota.
Dowds CM; Blumberg RS; Zeissig S
Clin Immunol; 2015 Aug; 159(2):128-33. PubMed ID: 25988859
[TBL] [Abstract][Full Text] [Related]
48. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
Aldars-García L; Marin AC; Chaparro M; Gisbert JP
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883
[TBL] [Abstract][Full Text] [Related]
49. Heme oxygenase-1 and carbon monoxide regulate intestinal homeostasis and mucosal immune responses to the enteric microbiota.
Onyiah JC; Sheikh SZ; Maharshak N; Otterbein LE; Plevy SE
Gut Microbes; 2014; 5(2):220-4. PubMed ID: 24637794
[TBL] [Abstract][Full Text] [Related]
50. [Intestinal immune response is regulated by gut microbe].
Tanemoto S; Sujino T; Kanai T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):408-415. PubMed ID: 29367525
[TBL] [Abstract][Full Text] [Related]
51. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
52. Intestinal microbiota and ulcerative colitis.
Ohkusa T; Koido S
J Infect Chemother; 2015 Nov; 21(11):761-8. PubMed ID: 26346678
[TBL] [Abstract][Full Text] [Related]
53. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
Satokari R
Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
[TBL] [Abstract][Full Text] [Related]
54. Roles of intestinal epithelial cells in the maintenance of gut homeostasis.
Okumura R; Takeda K
Exp Mol Med; 2017 May; 49(5):e338. PubMed ID: 28546564
[TBL] [Abstract][Full Text] [Related]
55. Fecal IgA Levels and Gut Microbiota Composition Are Regulated by Invariant Natural Killer T Cells.
de Aguiar CF; Castoldi A; Amano MT; Ignacio A; Terra FF; Cruz M; Felizardo RJF; Braga TT; Davanzo GG; Gambarini V; Antonio T; Antiorio ATFB; Hiyane MI; Morais da Fonseca D; Andrade-Oliveira V; Câmara NOS
Inflamm Bowel Dis; 2020 Apr; 26(5):697-708. PubMed ID: 31819985
[TBL] [Abstract][Full Text] [Related]
56. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function.
Schoultz I; Keita ÅV
Cells; 2019 Feb; 8(2):. PubMed ID: 30813280
[TBL] [Abstract][Full Text] [Related]
57. How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology.
Frosali S; Pagliari D; Gambassi G; Landolfi R; Pandolfi F; Cianci R
J Immunol Res; 2015; 2015():489821. PubMed ID: 26090491
[TBL] [Abstract][Full Text] [Related]
58. High-affinity monoclonal IgA regulates gut microbiota and prevents colitis in mice.
Okai S; Usui F; Yokota S; Hori-I Y; Hasegawa M; Nakamura T; Kurosawa M; Okada S; Yamamoto K; Nishiyama E; Mori H; Yamada T; Kurokawa K; Matsumoto S; Nanno M; Naito T; Watanabe Y; Kato T; Miyauchi E; Ohno H; Shinkura R
Nat Microbiol; 2016 Jul; 1(9):16103. PubMed ID: 27562257
[TBL] [Abstract][Full Text] [Related]
59. The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis.
Abt MC; Artis D
Curr Opin Gastroenterol; 2009 Nov; 25(6):496-502. PubMed ID: 19770652
[TBL] [Abstract][Full Text] [Related]
60. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.
Wang ZK; Yang YS; Chen Y; Yuan J; Sun G; Peng LH
World J Gastroenterol; 2014 Oct; 20(40):14805-20. PubMed ID: 25356041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
